This is a preview of subscription content, log in via an institution to check access.
Reference
Li Y, et al. Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability. Molecular Diagnosis and Therapy : 5 Dec 2017. Available from: URL: http://doi.org/10.1007/s40291-017-0309-5
Rights and permissions
About this article
Cite this article
Chromosomal microarray analysis cost effective in USA. PharmacoEcon Outcomes News 794, 11 (2018). https://doi.org/10.1007/s40274-018-4609-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4609-8